But out of all the supplements and drugs he takes for 'living healthy forever', one key medicine that Bryan and other ...

Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...

Tech entrepreneur and longevity advocate Bryan Johnson has discontinued his use of rapamycin, a controversial anti-ageing drug, after concerns it may have accelerated ageing rather than reversed it.